Cargando…
The need to define “who” rather than “if” for ECMO in COVID-19
Autores principales: | Whebell, Stephen, Zhang, Joe, Lewis, Rebecca, Berry, Michael, Ledot, Stephane, Retter, Andrew, Camporota, Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112247/ https://www.ncbi.nlm.nih.gov/pubmed/35579687 http://dx.doi.org/10.1007/s00134-022-06732-y |
Ejemplares similares
-
Survival benefit of extracorporeal membrane oxygenation in severe COVID-19: a multi-centre-matched cohort study
por: Whebell, Stephen, et al.
Publicado: (2022) -
Correction to: Survival benefit of extracorporeal membrane oxygenation in severe COVID-19: a multi-centre-matched cohort study
por: Whebell, Stephen, et al.
Publicado: (2022) -
Consensus on the referral and admission of patients with severe respiratory failure to the NHS ECMO service
por: Camporota, Luigi, et al.
Publicado: (2021) -
Re: Insight into ECMO, mortality and ARDS: a nationwide analysis of 45,647 ECMO runs (Friedrichson et al., Critical Care, January 2021)
por: Warren, Alex, et al.
Publicado: (2021) -
Phenotypes of severe COVID-19 ARDS receiving extracorporeal membrane oxygenation
por: Zhang, Joe, et al.
Publicado: (2021)